Preventing Alzheimer's disease-related gray matter atrophy by B-vitamin treatment.

Preventing Alzheimer's disease-related gray matter atrophy by B-vitamin treatment.

Show other versions (1)

Is it possible to prevent atrophy of key brain regions related to cognitive decline and Alzheimer's disease (AD)? One approach is to modify nongenetic risk factors, for instance by lowering elevated plasma homocysteine using B vitamins. In an initial, randomized controlled study on elderly subj...

Full description

Bibliographic Details
Main Authors:	Douaud, G, Refsum, H, de Jager, C, Jacoby, R, Nichols, T, Smith, S, Smith, A
Format:	Journal article
Language:	English
Published:	2013

Similar Items

Preventing Alzheimer's disease-related gray matter atrophy by B-vitamin treatment
by: Douaud, G, et al.
Published: (2013)

Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial
by: Smith, A, et al.
Published: (2010)

Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial.
by: Smith, A, et al.
Published: (2010)

Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial.
by: Smith, A, et al.
Published: (2010)

Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial.
by: de Jager, C, et al.
Published: (2012)

Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: A randomized controlled trial
by: De Jager, C, et al.
Published: (2012)

Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial.
by: A David Smith, et al.
Published: (2010-09-01)

Low vitamin B-12 status in confirmed Alzheimer's disease as revealed by serum holotranscobalamin.
by: Refsum, H, et al.
Published: (2003)

Evidence-based prevention and treatment of dementia
by: Smith, A, et al.
Published: (2016)

Association between gray matter atrophy, cerebral hypoperfusion, and cognitive impairment in Alzheimer’s disease
by: Haoyang Dong, et al.
Published: (2023-04-01)

Omega-3 Fatty Acid Status Enhances the Prevention of Cognitive Decline by B Vitamins in Mild Cognitive Impairment
by: Oulhaj, A, et al.
Published: (2016)

Vitamin B-12 and cognition in the elderly.
by: Smith, A, et al.
Published: (2009)

Homocysteine, B vitamins, and cardiovascular disease.
by: Refsum, H, et al.
Published: (2006)

Homocysteine, B vitamins, and cognitive impairment
by: Smith, A, et al.
Published: (2016)

Homocysteine, B vitamins, and cardiovascular disease
by: Refsum, H, et al.
Published: (2006)

Vitamin B12
by: Smith, A, et al.
Published: (2018)

Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease.
by: Clarke, R, et al.
Published: (1998)

Are we ready for mandatory fortification with vitamin B-12?
by: Refsum, H, et al.
Published: (2008)

Regional Gray Matter Atrophy Coexistent with Occipital Periventricular White Matter Hyper Intensities
by: Dazhi Duan, et al.
Published: (2016-09-01)

Gray Matter Atrophy to Explain Subclinical Oculomotor Deficit in Multiple Sclerosis
by: Bálint Kincses, et al.
Published: (2019-06-01)

Gray matter atrophy in multiple sclerosis despite clinical and lesion stability during natalizumab treatment.
by: Fredrika Koskimäki, et al.
Published: (2018-01-01)

The vitamin D receptor gene is associated with Alzheimer's disease
by: Lehmann, D, et al.
Published: (2011)

The vitamin D receptor gene is associated with Alzheimer's disease.
by: Lehmann, D, et al.
Published: (2011)

Brain Gray Matter Atrophy and Functional Connectivity Remodeling in Patients With Chronic LHON
by: Qin Tian, et al.
Published: (2022-05-01)

Voxel-Based Meta-Analysis of Gray Matter Abnormalities in Multiple System Atrophy
by: Junyu Lin, et al.
Published: (2020-11-01)

Do we need to reconsider the desirable blood level of vitamin B12?
by: David Smith, A, et al.
Published: (2012)

Vitamin B12 status and rate of brain volume loss in community-dwelling elderly.
by: Vogiatzoglou, A, et al.
Published: (2008)

Vitamin B12 status and rate of brain volume loss in community-dwelling elderly
by: Vogiatzoglou, A, et al.
Published: (2008)

Measurement of whole-brain and gray matter atrophy in multiple sclerosis: assessment with MR imaging
by: Storelli, L, et al.
Published: (2018)

The causal link between cardiometabolic risk factors and gray matter atrophy: An exploratory study
by: Vibujithan Vigneshwaran, et al.
Published: (2023-11-01)

Odor Identification and Regional Gray Matter Atrophy in Patients with Alzheimer’s Disease, Parkinson’s Disease, and the Healthy Elderly: A Cross-Sectional Structural MRI Study
by: Simonas Jesmanas, et al.
Published: (2021-09-01)

Jacobian integration method increases the statistical power to measure gray matter atrophy in multiple sclerosis
by: Kunio Nakamura, et al.
Published: (2014-01-01)

Gray Matter Atrophy Is Associated With Cognitive Impairment in Patients With Presbycusis: A Comprehensive Morphometric Study
by: Fuxin Ren, et al.
Published: (2018-10-01)

Cortical Gray Matter and Hippocampal Atrophy in Idiopathic Rapid Eye Movement Sleep Behavior Disorder
by: Anna Campabadal, et al.
Published: (2019-04-01)

Gray Matter Atrophy in Amnestic Mild Cognitive Impairment: A Voxel-Based Meta-Analysis
by: Jinhuan Zhang, et al.
Published: (2021-03-01)

The yearly rate of Relative Thalamic Atrophy (yrRTA): a simple 2D/3D method for estimating deep gray matter atrophy in Multiple Sclerosis
by: Manuel eMenéndez-González, et al.
Published: (2014-08-01)

Gray Matter Atrophy in Parkinson’s Disease and the Parkinsonian Variant of Multiple System Atrophy: A Combined ROI- and Voxel-Based Morphometric Study
by: Xiaorui Cui, et al.
Published: (2020-06-01)

Unraveling the link: white matter damage, gray matter atrophy and memory impairment in patients with subcortical ischemic vascular disease
by: Jing Huang, et al.
Published: (2024-02-01)

Polarization-sensitive optical coherence tomography reveals gray matter and white matter atrophy in SCA1 mouse models
by: Chao J. Liu, et al.
Published: (2018-08-01)

Homocysteine as a predictor of cognitive decline in Alzheimer's disease
by: Oulhaj, A, et al.
Published: (2010)